Clinical implication of ivabradine therapy in patients receiving hemodialysis

^*この論文の責任著者

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	469
ページ数	1
ジャーナル	Therapeutic Apheresis and Dialysis
巻	28
号	3
DOI	https://doi.org/10.1111/1744-9987.14112
出版ステータス	出版済み - 2024/06

ASJC Scopus 主題領域

@article{9935560572f6454c972e9935a48fa71e,

title = "Clinical implication of ivabradine therapy in patients receiving hemodialysis",

author = "Naoya Kataoka and Teruhiko Imamura",

year = "2024",

month = jun,

doi = "10.1111/1744-9987.14112",

language = "英語",

volume = "28",

pages = "469",

journal = "Therapeutic Apheresis and Dialysis",

issn = "1744-9979",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Clinical implication of ivabradine therapy in patients receiving hemodialysis

AU - Kataoka, Naoya

AU - Imamura, Teruhiko

PY - 2024/6

Y1 - 2024/6

UR - http://www.scopus.com/inward/record.url?scp=85185443102&partnerID=8YFLogxK

U2 - 10.1111/1744-9987.14112

DO - 10.1111/1744-9987.14112

M3 - Letter

C2 - 38351539

AN - SCOPUS:85185443102

SN - 1744-9979

VL - 28

SP - 469

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

IS - 3

ER -